St. Jude Medical paid about $123 million to acquire a developer of small, leadless cardiac pacemakers not yet approved in the U.S. The deal follows St. Jude's 2011 recall of leads for two of its pacemakers.
The deal with Nanostim, an early-stage medical-device company based in Milpitas, Calif., has been in the works for several years.
Read more »
Eye-care firms continue to be a hot target this year as pharmaceutical and medical-device firms see a growing market for ophthalmology procedures.
Abbott Laboratories, the Illinois-based medical-device giant, is shelling out $250 million for OptiMedica Corp., which makes technology for laser-assisted cataract surgery.
Read more »
